Vaccination — Active and Passive Immunity

Q1 — Sample Band 6 response (8 marks), annotated

Between 1988 and 2024, global wild poliovirus cases fell from approximately 350,000 per year to fewer than 20 — a reduction of more than 99.9% in 36 years. [1 — quantitative trend with appropriate figures] This demonstrates that sustained, coordinated mass vaccination is capable of driving a globally endemic infectious disease to near-extinction: the Oral Polio Vaccine (Sabin) and Inactivated Polio Vaccine (Salk) both generate artificial active immunity, triggering clonal selection and memory-cell formation in each recipient, and at sufficient coverage they collectively push the effective reproduction number below 1 so that transmission chains cannot be sustained. [implicit across criterion 1]

India’s certification as polio-free in 2014 represented an extraordinary logistical milestone precisely because of the country’s scale and complexity. Polio has an R&sub0; of approximately 5–7, giving a herd immunity threshold of approximately 80–85% (threshold = 1 − 1/R&sub0; = 1 − 1/6 ≈ 83%). Achieving and sustaining this coverage level across 1.4 billion people — including dense urban slums, remote rural communities, and populations with historically low health-system access — required coordinated campaigns reaching hundreds of millions of children per round. When the threshold was crossed and maintained, wild poliovirus could no longer find sufficient susceptible hosts to sustain chains of transmission, and the virus was eliminated from India. [1 — India milestone with R&sub0; and threshold calculation]

The two barriers preventing eradication in Pakistan and Afghanistan are both non-biological in nature, which is significant. First, armed conflict has repeatedly disrupted vaccination campaigns: warring factions control access to regions, displacement of populations makes target children impossible to locate or reach, and the logistical infrastructure required to maintain cold-chain vaccine delivery collapses in active conflict zones. Second, deliberate misinformation — including false claims that the oral polio vaccine caused infertility or was part of a covert foreign intelligence operation — has eroded community trust in vaccination, particularly in Pakistan, leading some families to refuse vaccination and creating susceptible clusters. Neither barrier reflects a failure of the vaccines themselves: both the Salk and Sabin vaccines are immunologically effective, and the poliovirus has not mutated to escape vaccine immunity (unlike influenza or HIV, which show rapid antigenic variation). [1 — barrier 1 (conflict/logistics) correctly identified as non-biological] [1 — barrier 2 (misinformation/distrust) correctly identified and distinguished from biological barriers]

Precisely characterising the current global status: polio has been eliminated from more than 120 countries — meaning wild poliovirus no longer circulates locally in those nations (though it still exists globally). Global eradication — permanent worldwide reduction to zero, with the virus no longer existing in nature — has not yet been achieved. Eradication remains the goal; elimination is the current status in most of the world. [1 — elimination and eradication applied precisely to current status]

Overall, the global polio vaccination program is among the most successful public health endeavours in history. It demonstrates definitively that vaccination at population scale can push a globally endemic disease to the brink of eradication. The immunological case is closed: the vaccines work, herd immunity is achievable, and the biology is not the problem. The last 0.1% of the challenge is a governance, security, and social trust problem, not an immunological one. Eradication is closer than it has ever been, and the obstacle is not the science of active immunity but the political and logistical conditions required to deliver it universally. [1 — evidence-based overall judgement distinguishing immunological success from governance obstacles]

Marking criteria:

• 1 mark — Describes the quantitative trend (350,000 in 1988 to fewer than 20 in 2024, or equivalent figures representing >99% reduction) and links it to vaccination effectiveness.
• 1 mark — Explains India’s milestone: correctly states polio R&sub0; (5–7), derives or states threshold (~80–85%), and explains why achieving this across 1.4 billion people was a logistical achievement that demonstrates herd immunity at scale.
• 1 mark — Identifies and correctly explains barrier 1 (armed conflict/geopolitical: disrupts campaigns, disables logistics, displaces populations) as non-biological.
• 1 mark — Identifies and correctly explains barrier 2 (misinformation/distrust: false claims, community refusal) as non-biological, and explicitly distinguishes from biological barriers (no animal reservoir, vaccine effective, virus not evading immunity).
• 1 mark — Correctly and precisely applies elimination (zero local transmission in a defined area, pathogen still exists elsewhere) to characterise most of the world and eradication (permanent global zero) as the unachieved goal.
• 1 mark — Reaches an overall evidence-based judgement that recognises the program as highly effective and frames the remaining obstacle as non-biological (governance/security/trust rather than vaccine science or immunology).
• 2 marks — Quality and precision of scientific language throughout: correct use of active immunity, memory cells, effective reproduction number, herd immunity threshold, clonal selection — award 1 for adequate terminology, 2 for consistently precise integration of multiple lesson concepts.

Q2 — Sample Band 6 response (7 marks), annotated

The claim is a mixture of partially true elements embedded in several significant biological errors and a fundamental misrepresentation of herd immunity. [1 — overall evaluative judgement]

Partially defensible element: For some pathogens, natural infection can produce broader immunity than a single vaccination course — exposure to the full pathogen may present more antigen epitopes than a targeted vaccine antigen, potentially generating a more diverse memory B-cell response. This is the basis of the observation of “hybrid immunity” (infection followed by vaccination) producing particularly durable antibody levels, as observed with SARS-CoV-2. [1 — concedes the one partially valid element correctly]

Error 1 — natural immunity is “always” better and controlled exposure is preferable: The claim ignores the cost of natural infection. Natural polio infection paralysed hundreds of thousands of children per year. Natural measles causes encephalitis in approximately 1 in 1,000 cases. Natural chickenpox can cause fatal pneumonia in immunocompromised individuals and establishes latent varicella-zoster virus that reactivates decades later as shingles. Natural COVID-19 killed millions globally. “Controlled exposure” is neither ethical nor practically feasible for severe diseases, and the immunity gained from natural infection does not justify subjecting individuals to the disease risk when vaccination can produce equivalent or superior long-term immunity with a fraction of the danger. [1 — correctly refutes “natural is always better/controlled exposure” with specific disease examples]

Error 2 — herd immunity is “just a theory” never proven in real populations: Herd immunity is empirically demonstrated, not theoretical. The lesson’s own data shows that when measles vaccination coverage exceeded 95% (the herd immunity threshold for measles with R&sub0; ≈ 12–18), annual cases fell to near zero. The global polio eradication data shows cases falling from 350,000 per year to fewer than 20 as vaccination coverage exceeded the ~80–85% threshold in successively more countries. Both examples demonstrate that once enough people are immune, transmission chains break and susceptible individuals gain indirect protection — which is exactly the definition of herd immunity operating in real populations. [1 — correctly refutes “just a theory” with empirical evidence from named vaccination programs]

Error 3 — “nothing dramatic” from a small coverage drop: The lesson data (Activity 02 and the lesson graph) shows that when measles coverage dropped from 97% to 89% — a drop of just 8 percentage points — annual cases rose from 3 to 1,240 — a more than 400-fold increase. This is because the relationship between coverage and case numbers near the threshold is non-linear: crossing below the herd immunity threshold moves the effective reproduction number back above 1, allowing chains that were previously extinguished to re-establish. Small drops below the threshold produce dramatically large outbreak consequences — precisely the opposite of the claim. [1 — correctly refutes “nothing dramatic” with quantitative lesson data]

Error 4 — vaccination “only lasts a few years”: This overgeneralises. Many vaccines produce memory cells that persist for decades or a lifetime: the measles vaccine confers lifelong immunity in most recipients after two doses. The yellow fever vaccine (a single dose) provides lifelong protection in the vast majority of recipients. Some vaccines do require boosters due to waning immunity (tetanus every 10 years) or antigenic variation (annual influenza), but these are exceptions rooted in the biology of specific pathogens, not a general property of vaccination. Memory B and T cells generated by active immunity — whether from infection or vaccination — can persist indefinitely in the lymph nodes and bone marrow. [1 — correctly refutes “only lasts a few years” with accurate nuance about duration variation]

Defensible reformulation of the full claim: “For some pathogens, natural infection may produce somewhat broader immune responses than targeted vaccines, but this difference does not justify deliberate exposure to diseases that can cause serious disability or death. Herd immunity is an empirically demonstrated population-level phenomenon that has been instrumental in reducing polio cases by over 99.9% globally and measles cases to near zero where coverage exceeds 95%. Small drops in vaccination coverage below the herd immunity threshold can produce dramatic outbreaks non-linearly. Most vaccines generate long-lasting or lifelong memory cell populations; where booster doses are needed, this reflects specific pathogen biology rather than a general failure of vaccination.” [1 — accurate overall reformulation integrating all corrected elements]

Marking criteria:

• 1 mark — States a clear overall evaluative judgement (e.g. the claim is a mixture of partially correct and significantly incorrect biological assertions).
• 1 mark — Correctly identifies the one defensible element (natural infection can produce broader immunity in some cases) without overstating it.
• 1 mark — Refutes “natural always better/controlled exposure” with at least one named example of disease risk from natural infection (polio paralysis, measles encephalitis, or equivalent).
• 1 mark — Refutes “herd immunity is just theory” with empirical evidence from a named vaccination program (polio eradication data, measles threshold crossing, or equivalent).
• 1 mark — Refutes “nothing dramatic from small coverage drop” with quantitative evidence showing non-linear relationship between coverage and cases near the threshold (e.g. 8% drop → 400-fold case increase).
• 1 mark — Refutes “vaccination only lasts a few years” with accurate distinction between vaccines that produce lifelong immunity and those requiring boosters, with a mechanistic explanation (memory B/T cells persist; booster need reflects pathogen biology).
• 1 mark — Produces a biologically defensible reformulation of the full claim that integrates all corrected elements using precise lesson terminology.